Integra LifeSciences to Showcase Innovations at Key Conferences

Integra LifeSciences Leadership Showcases Commitment
Integra LifeSciences Holdings Corporation (Nasdaq: IART) is preparing for a significant presence at two prominent investor healthcare conferences soon. This event highlights the company’s ongoing dedication to advancing medical technology and enhancing patient care.
Upcoming Investor Healthcare Conferences
CEO Mojdeh Poul and CFO Lea Knight will represent Integra LifeSciences at these vital gatherings:
Wells Fargo Healthcare Conference
Scheduled for September 3, this conference will take place at 12:45 p.m. ET. It presents an opportunity for the company's leadership to engage with investors, sharing insights on their innovative approaches to medical technology.
Morgan Stanley Healthcare Conference
The following week, on September 10 at 8:30 a.m. ET, Integra will participate in the Morgan Stanley Healthcare Conference. The focus during this presentation will be on recent advancements and strategic initiatives that continue to place Integra at the forefront of the industry.
Live Broadcasts and Accessibility
For those unable to attend in person, a live webcast of both presentations will be accessible via the Integra LifeSciences investor relations website. This ensures that interested parties can follow the latest discussions and strategic insights directly from the leadership team.
About Integra LifeSciences
At the heart of Integra LifeSciences is a commitment to restoring and enhancing lives through innovative medical solutions. The company focuses on developing cutting-edge treatment pathways that improve patient outcomes and set new benchmarks in surgical, neurologic, and regenerative care. With a robust portfolio of high-quality brands, Integra is dedicated to providing comprehensive solutions tailored to meet the needs of healthcare professionals and patients alike.
Contact Information
For any inquiries, the investor relations contact is Chris Ward, reachable at (609) 772-7736, or via email at chris.ward@integralife.com.
For media inquiries, Laurene Isip can be contacted at (609) 208-8121, or by emailing laurene.isip@integralife.com.
Frequently Asked Questions
What recent developments will Integra LifeSciences discuss?
Integra LifeSciences plans to share insights about its latest innovations in medical technology and how these advancements align with its commitment to patient care.
Who will represent Integra at the conferences?
CEO Mojdeh Poul and CFO Lea Knight will represent the company, presenting valuable information on its initiatives and performance.
Are the presentations available for public viewing?
Yes, a live webcast of the presentations will be available on Integra's investor relations website for anyone interested.
What is the focus of Integra's commitment?
Integra's commitment focuses on restoring patients' lives through innovative surgical, neurologic, and regenerative care treatments.
How can I get in touch with Integra's investor relations?
You can contact Chris Ward at (609) 772-7736 or by email at chris.ward@integralife.com.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.